Detalhe da pesquisa
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38153814
2.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38060001
3.
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.
Am J Hematol
; 99(1): 57-67, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38014779
4.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36932983
5.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33889952
6.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35363892
7.
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia.
Br J Haematol
; 198(5): 916-922, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35701886
8.
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
Blood
; 136(2): 171-182, 2020 07 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32266380
9.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31869407
10.
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
Ann Hematol
; 101(5): 963-978, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35201417
11.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer
; 127(15): 2657-2665, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33794557
12.
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study.
Br J Haematol
; 193(2): 386-396, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33618438
13.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 193(2): 356-368, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33222197
14.
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Hematol Oncol
; 39(3): 409-418, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33590502
15.
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
Cancer
; 126(6): 1243-1252, 2020 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31860137
16.
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
Hematol Oncol
; 38(3): 372-380, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32271957
17.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol
; 95(2): 156-166, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31721282
18.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31816122
19.
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
Mycoses
; 63(10): 1094-1100, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32697010
20.
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.
Br J Haematol
; 184(3): 424-430, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30408157